Ferroptosis Signaling Promotes the Release of Misfolded Proteins via Exosomes to Rescue ER Stress in Hepatocellular Carcinoma

The inhibition of ferroptosis signaling synergized with bortezomib, a clinically used proteasome inhibitor, to suppress the viability of hepatocellular carcinoma cells in vitro and in vivo.